SCHEMBL17885205

SCHEMBL17885205

c1ccc(-n2c3ccccc3c3cc(-c4ccc5oc6ccc(-c7ccc8[nH]c9ccccc9c8c7)cc6c5c4)ccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ ATM Q13315 1/20 0.44
▸ AHR P35869 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ SENP7 Q9BQF6 1/20 0.37
▸ SENP6 Q9GZR1 1/20 0.37
▸ KIF11 P52732 3/20 0.37
▸ PDE7A Q13946 2/20 0.36
▸ PDE7B Q9NP56 2/20 0.36
▸ HPGD P15428 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ CHEK2 O96017 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ GPR3 P46089 1/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17253682 0.95 KDM4E (0.44) KDM4EL3MBTL1ATMAHRCASP3
SCHEMBL20715302 0.94 KDM4E (0.43) KDM4EL3MBTL1ATMAHRCASP3
SCHEMBL29362456 0.91 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL261376 0.91 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL29827404 0.91 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL24304094 0.91 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL15962643 0.91 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL29410818 0.91 KDM4E (0.53) KDM4EL3MBTL1ATMAHRKIF11
SCHEMBL15962644 0.91 CASP3 (0.38) KDM4EL3MBTL1ATMAHRCASP3
SCHEMBL17166791 0.91 CASP3 (0.38) KDM4EL3MBTL1ATMAHRCASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237409-B1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2022-01-05 — — EP disclosed
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2019-02-07 — — US disclosed
WO-2016102040-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS MERCK PATENT GMBH (DE) 2016-06-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190044071-A1 CARBAZOLES WITH TWO DIBENZOFURAN OR DIBENZOTHIOPHENE SUBSTITUENTS BRD3, BRPF3, DDT KDM4E 2631/4885L3MBTL1 638/4885ATM 3655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback